In this episode of Cannabis Unlocked, Jasper Gallo (Director of Corporate Development at PharmaCann) and Jeremy Nelson (Associate Director of Corporate Development at PharmaCann) sit down with Jordan Youkilis (KEY Investment Partners Founding Partner) to discuss current and future state of cannabis M&A, and PharmaCann's growth strategy through organic license wins along with acquisitions. This conversation starts with Jasper and Jeremys individual journeys towards cannabis, their path into PharmaCann along with a high level overview of PharmaCann. From there, Jasper, Jeremy and Jordan cover some of the advantages scale provides cannabis businesses and speak to how PharmaCann has grown, through a mix of organic license wins through application processes as well as through M&A. The talk continues with Jasper and Jeremy's perspectives on the current state of cannabis M&A in regards to the falling valuations of cannabis business' and what impact the overall economy has on cannabis M&A transactions. The conversation wraps up with Jasper and Jeremys thoughts on markets with an uncapped amount of licenses, the value of building a market presence in limited license states and unlimited license states, and how potential federal changes impact the M&A and investment side of cannabis. Please enjoy!